United States
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
5.16
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
2 |
4.71
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
3 |
3.11
|
Sept. 30, 2024 | USD 627.71 | 1.49% |
|
United States |
|
4 |
2.71
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
|
5 |
2.38
|
Sept. 30, 2024 | USD 8.97 | -1.75% |
|
United States |
|
6 |
2.34
|
Dec. 31, 2023 | USD 3.79 | 1.24% |
|
United States |
|
7 |
2.32
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
8 |
2.23
|
Sept. 30, 2024 | USD 38.98 | 0.72% |
|
United States |
|
9 |
1.77
|
Nov. 9, 2024 | USD 59.92 | 0.72% |
|
United States |
|
10 |
1.09
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
11 |
1.02
|
March 31, 2024 | USD 39.22 | 1.63% |
|
United States |
|
12 |
0.95
|
Sept. 30, 2024 | USD 1.05 | -7.08% |
|
United States |
|
13 |
0.89
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
14 |
0.88
|
Sept. 30, 2024 | USD 54.16 | 0.43% |
|
United States |
|
15 |
0.85
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
16 |
0.83
|
Sept. 26, 2024 | USD 95.99 | -0.72% |
|
United States |
|
17 |
0.79
|
Sept. 30, 2024 | USD 4.15 | -1.66% |
|
United States |
|
18 |
0.66
|
Sept. 30, 2024 | USD 1.64 | -2.96% |
|
United States |
|
19 |
0.59
|
Sept. 30, 2024 | USD 17.68 | 0.68% |
|
United States |
|
20 |
0.51
|
Sept. 30, 2024 | USD 42.32 | NA |
|
United States |
|
21 |
0.50
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
22 |
0.38
|
Sept. 28, 2024 | USD 63.79 | -0.65% |
|
United States |
|
23 |
0.33
|
Nov. 2, 2024 | USD 11.50 | 1.23% |
|
United States |
|
24 |
0.13
|
Sept. 28, 2024 | USD 66.75 | 0.48% |
|
United States |
|
25 |
0.12
|
Sept. 30, 2024 | USD 12.40 | -1.20% |
|
United States |
|
26 |
0.11
|
Oct. 31, 2024 | USD 72.63 | 1.31% |
|
United States |
|
27 |
0.01
|
Sept. 30, 2024 | USD 4.88 | 0.62% |
|
United States |
|
28 |
0.01
|
Sept. 28, 2024 | USD 35.65 | -0.17% |
|
United States |
|
29 |
-1.08
|
Sept. 30, 2024 | USD 5.67 | 2.35% |
|
United States |
|
30 |
-2.54
|
Sept. 30, 2024 | USD 6.18 | -4.33% |
|
United States |
|
31 |
-3.21
|
Nov. 2, 2024 | USD 36.79 | 0.03% |
|
United States |
|
32 |
-3.37
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
33 |
-6.92
|
Sept. 30, 2024 | USD 14.98 | -0.13% |
|
United States |
The Drugstores & Retail Pharmacies company in United States with the highest Debt to Equity Ratio is Cencora (NYSE: COR) at 5.16.
The Drugstores & Retail Pharmacies company in United States with the lowest Debt to Equity Ratio is Xponential Fitness, Inc. (NYSE: XPOF) at -6.92.
The top 10 Drugstores & Retail Pharmacies companies in United States by Debt to Equity Ratio are Cencora, Albertsons Companies, Inc., Lennox International Inc., Walgreens Boots Alliance, Inc., Icahn Enterprises L.P., Pilulka Lékárny a.s., BrightSpring Health Services, Inc. Common Stock, Natural Grocers by Vitamin Cottage, Inc., The Kroger Co. and CVS Health Corporation.
The bottom 10 Drugstores & Retail Pharmacies companies in United States by Debt to Equity Ratio are Xponential Fitness, Inc., McKesson Corporation, Bath & Body Works, Inc., Herbalife Nutrition Ltd., biote Corp., Sturm, Ruger & Company, Inc., PetMed Express, Inc., Brady Corporation, ShotSpotter, Inc. and Weis Markets, Inc..